Press Release

Theranos Adds Silicon Valley Executive to Board of Directors

Theranos today announced that veteran technology executive Daniel J.
Warmenhoven has been appointed to the Theranos Board of Directors,
effective immediately.

“Mr. Warmenhoven has deep experience in building great companies,”
Theranos CEO Elizabeth Holmes said. “His insights will be extremely
useful as we now work to commercialize our miniLab and proprietary
software systems.”

Warmenhoven brings decades of leadership experience in Silicon Valley
and the technology industry. He served as chief executive officer of
NetApp from 1994 through 2009 and was executive chairman of the NetApp
board of directors from 2009 through 2014. During that time, NetApp grew
to become a multibillion-dollar company and a recognized market leader
in networked storage. Warmenhoven also led the company’s initial public
offering.

Previously, Warmenhoven served as chairman, president, and CEO of
Network Equipment Technologies, a telecommunications manufacturer. He
has also held senior management positions at Hewlett-Packard Co., and
prior to that, worked for over 10 years at IBM Corporation. He is
currently a director on the board of Bechtel Group, Inc. and Palo Alto
Networks.

“Theranos’ inventions position it to meaningfully contribute to
accessible, affordable health care across a broad range of settings,”
Warmenhoven said. “I have confidence in the company’s return to its
technology roots, and I look forward to helping guide it to success.”

Warmenhoven replaces retiring director Riley P. Bechtel, who has health
issues, effective immediately. “It has been a privilege to have Riley as
a mentor and director of our company,” said Holmes. “He is an amazing
leader. We are proud to call him a shareholder and will miss him on our
board.”

Theranos also announced that, effective Jan. 1, 2017, it will retire its
Board of Counselors structure as part of an ongoing evolution and
consolidation of the Company’s corporate advisory framework. “We are
deeply appreciative of the distinguished individuals who have served on
our Board of Counselors.” said Holmes. “We have been so fortunate to
have the counsel of this group, and I am grateful for their ongoing
support of our company.”

About Theranos

Founded in 2003 by Elizabeth Holmes, Theranos, Inc. is a health
technology company headquartered in Palo Alto, Calif. Its proprietary
miniLab platform is designed to facilitate small-sample collection,
testing and rapid communication of diagnostic information in distributed
settings, enabling earlier detection and intervention. To learn more
about Theranos, visit www.theranos.com.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.